This is a reason to go long though. Presence in over 38 countries requires capital to increase treatment centers and train Doctors.
- Also, every time they have expanded in new markets, revenues rose. They rose by about 43% between 2021 - 2023.
- Insurers in the Uk and Spain are increasingly accepting OncoSil treatment so this momentum just needs to persist.
News: OSL Oncosil Medical Seeks Trading Halt, page-24
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.38M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 900000 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 597487 | 2 |
View Market Depth
| Last trade - 08.48am 08/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |
Day chart unavailable